Faculty Bibliography

Hughes and Lerman have received consulting fees and grants from several for-profit and nonprofit organizations that develop or promote smoking cessation products and services, including nicotine replacement therapies

Arthur Caplan is the Emmanuel and Robert Hart Professor of Bioethics, Chair of the Department of Medical Ethics and the Director of the Center for Bioethics at the University of Pennsylvania. His research interests are transplantation research ethics, genetics, reproductive technologies, health policy, and general bioethics. He is the author/editor of twenty-five hooks and more than 500 papers. He writes a regular column for MSNBC.com, and is a frequent guest and commentator for major broadcast and print media outlets. Among his many appointments are chair of the Advisory Committee to the United Nations on Human Cloning and member of the Presidential Advisory Committee on Gulf War Illnesses. Caplan is the recipient of many awards including Person of the Year-2001 from USA Today, and one of the fifty most influential people in American Health Care by Modern Health Care magazine

If your house is full of radioactive radon gas leaking up from underlying rocks, your risk for lung cancer is high no matter what genes you do or don't have

Type "genetic testing" on an Internet search engine and then hang on. You will be in for quite a ride. There is an endless parade of companies touting genetic tests for everything, including determining whether your kid has the potential to be a star athlete, finding out whether your ancestors were kings or ne'er-do-wells, finding a date, optimizing your diet, or knowing what diet to use if your intake is not optimal. Apparently, there is more self-discovery to be had by spitting your saliva into a cup and sending it off to be genetically analyzed than in a whole month of Dr. Drew

Book The proper ends do justify the means During the Nuremberg trials, convened at the end of World War II, lawyers for the German defendants, politicians accused of crimes against humanity, and physicians accused of euthanasia and barbaric medical experimentation offered the rationale of "kriegsraison" to exculpate their clients

Medical tourism on the part of those seeking therapies for terminal diseases has a long and inglorious tradition. For many decades, those diagnosed with terminal cancer have sought care at all manner of clinics, institutes, and hospitals in nations all over the world. From laetrile, to the Issels treatment, to Hoxsey therapy, to ozone treatment, to Gerson therapy and hundreds more, the parade of fraud, deceit, scamming and ripoffs almost defies cataloguing. Here, Caplan and Levine suggest that patient advocacy organizations, cellular therapy professionals and clinicians, professional societies, and international regulatory bodies must act together to help patients distinguish hope from hype in the realm of stem-cell-based medical treatments